vs

Side-by-side financial comparison of CF BANKSHARES INC. (CFBK) and Sol-Gel Technologies Ltd. (SLGL). Click either name above to swap in a different company.

Sol-Gel Technologies Ltd. is the larger business by last-quarter revenue ($17.3M vs $15.7M, roughly 1.1× CF BANKSHARES INC.). Sol-Gel Technologies Ltd. runs the higher net margin — 67.3% vs 40.0%, a 27.2% gap on every dollar of revenue. On growth, Sol-Gel Technologies Ltd. posted the faster year-over-year revenue change (217.7% vs 12.6%).

CF Bankshares Inc. is a U.S.-based regional bank holding company operating through its community bank subsidiary. It offers a full suite of personal and commercial banking solutions including deposit products, various loan options, wealth management services and digital banking tools, primarily serving individual consumers and small-to-medium business clients across the U.S. Midwest region.

Sol-Gel Technologies Ltd. is a specialty biopharmaceutical company focused on developing and commercializing innovative dermatology treatments. Leveraging its proprietary sol-gel delivery technology, it creates topical therapies for common skin conditions including acne, rosacea and atopic dermatitis, with primary markets across North America and Europe, partnering with established healthcare firms to expand product reach.

CFBK vs SLGL — Head-to-Head

Bigger by revenue
SLGL
SLGL
1.1× larger
SLGL
$17.3M
$15.7M
CFBK
Growing faster (revenue YoY)
SLGL
SLGL
+205.1% gap
SLGL
217.7%
12.6%
CFBK
Higher net margin
SLGL
SLGL
27.2% more per $
SLGL
67.3%
40.0%
CFBK

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
CFBK
CFBK
SLGL
SLGL
Revenue
$15.7M
$17.3M
Net Profit
$5.7M
$11.6M
Gross Margin
Operating Margin
43.4%
65.1%
Net Margin
40.0%
67.3%
Revenue YoY
12.6%
217.7%
Net Profit YoY
29.9%
487.6%
EPS (diluted)
$0.88
$4.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CFBK
CFBK
SLGL
SLGL
Q4 25
$15.7M
Q3 25
$15.5M
Q2 25
$15.6M
$17.3M
Q1 25
$14.1M
Q4 24
$14.0M
Q3 24
$13.1M
Q2 24
$12.6M
$5.4M
Q1 24
$12.2M
Net Profit
CFBK
CFBK
SLGL
SLGL
Q4 25
$5.7M
Q3 25
$2.3M
Q2 25
$5.0M
$11.6M
Q1 25
$4.4M
Q4 24
$4.4M
Q3 24
$4.2M
Q2 24
$1.7M
$2.0M
Q1 24
$3.1M
Operating Margin
CFBK
CFBK
SLGL
SLGL
Q4 25
43.4%
Q3 25
17.5%
Q2 25
41.1%
65.1%
Q1 25
39.5%
Q4 24
36.9%
Q3 24
40.4%
Q2 24
15.4%
29.9%
Q1 24
30.9%
Net Margin
CFBK
CFBK
SLGL
SLGL
Q4 25
40.0%
Q3 25
15.1%
Q2 25
32.3%
67.3%
Q1 25
31.4%
Q4 24
35.2%
Q3 24
32.2%
Q2 24
13.5%
36.4%
Q1 24
25.2%
EPS (diluted)
CFBK
CFBK
SLGL
SLGL
Q4 25
$0.88
Q3 25
$0.36
Q2 25
$0.77
$4.17
Q1 25
$0.68
Q4 24
$0.68
Q3 24
$0.65
Q2 24
$0.26
$0.71
Q1 24
$0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CFBK
CFBK
SLGL
SLGL
Cash + ST InvestmentsLiquidity on hand
$259.0M
$24.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$184.4M
$31.9M
Total Assets
$2.1B
$39.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CFBK
CFBK
SLGL
SLGL
Q4 25
$259.0M
Q3 25
$272.4M
Q2 25
$275.7M
$24.3M
Q1 25
$241.0M
Q4 24
$235.3M
Q3 24
$233.5M
Q2 24
$241.8M
$26.5M
Q1 24
$236.9M
Stockholders' Equity
CFBK
CFBK
SLGL
SLGL
Q4 25
$184.4M
Q3 25
$179.3M
Q2 25
$177.0M
$31.9M
Q1 25
$172.7M
Q4 24
$168.4M
Q3 24
$164.0M
Q2 24
$159.6M
$34.9M
Q1 24
$158.0M
Total Assets
CFBK
CFBK
SLGL
SLGL
Q4 25
$2.1B
Q3 25
$2.1B
Q2 25
$2.1B
$39.3M
Q1 25
$2.1B
Q4 24
$2.1B
Q3 24
$2.1B
Q2 24
$2.0B
$42.0M
Q1 24
$2.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CFBK
CFBK
SLGL
SLGL
Operating Cash FlowLast quarter
$18.7M
Free Cash FlowOCF − Capex
$18.2M
FCF MarginFCF / Revenue
115.6%
Capex IntensityCapex / Revenue
3.1%
Cash ConversionOCF / Net Profit
3.26×
TTM Free Cash FlowTrailing 4 quarters
$33.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CFBK
CFBK
SLGL
SLGL
Q4 25
$18.7M
Q3 25
$5.5M
Q2 25
$8.0M
Q1 25
$2.2M
Q4 24
$14.2M
Q3 24
$-1.3M
Q2 24
$4.0M
Q1 24
$-1.2M
Free Cash Flow
CFBK
CFBK
SLGL
SLGL
Q4 25
$18.2M
Q3 25
$5.2M
Q2 25
$7.8M
Q1 25
$2.2M
Q4 24
$13.9M
Q3 24
$-1.3M
Q2 24
$4.0M
Q1 24
$-1.2M
FCF Margin
CFBK
CFBK
SLGL
SLGL
Q4 25
115.6%
Q3 25
33.6%
Q2 25
50.3%
Q1 25
15.2%
Q4 24
99.6%
Q3 24
-9.9%
Q2 24
31.6%
Q1 24
-9.5%
Capex Intensity
CFBK
CFBK
SLGL
SLGL
Q4 25
3.1%
Q3 25
1.7%
Q2 25
0.7%
Q1 25
0.4%
Q4 24
1.9%
Q3 24
0.2%
Q2 24
0.1%
Q1 24
0.0%
Cash Conversion
CFBK
CFBK
SLGL
SLGL
Q4 25
3.26×
Q3 25
2.34×
Q2 25
1.58×
Q1 25
0.50×
Q4 24
3.21×
Q3 24
-0.30×
Q2 24
2.35×
Q1 24
-0.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons